"
Europe/Sponsors
From 2013.igem.org
| Line 2: | Line 2: | ||
<html> | <html> | ||
| + | <style type = 'text/css'> | ||
| + | p.padding | ||
| + | { | ||
| + | |||
| + | padding-left:400px; | ||
| + | } | ||
| + | </style> | ||
<div align=justify > | <div align=justify > | ||
<br/> | <br/> | ||
| Line 26: | Line 33: | ||
<A href="http://www.erasynbio.eu/" title="ERASynbio"><IMG Align="left" src="https://static.igem.org/mediawiki/2013/c/c2/Logo-erasynbio.jpg" style="margin-right:50px;" border="0" alt="ERASynbio" width="350" hspace="20"/></A> | <A href="http://www.erasynbio.eu/" title="ERASynbio"><IMG Align="left" src="https://static.igem.org/mediawiki/2013/c/c2/Logo-erasynbio.jpg" style="margin-right:50px;" border="0" alt="ERASynbio" width="350" hspace="20"/></A> | ||
| - | <p>The central idea of ERASynBio is <b>to promote the robust development of Synthetic Biology</b> by structuring and coordinating national efforts and investment. ERASynBio will develop a strategic research agenda / white paper, which will support the emergence of national Synthetic Biology programmes and which will lay the ground for transnational funding activities via joint calls in the project. ERASynBio will stimulate and tackle the interdisciplinary nature and immaturity by offering training and educational possibilities, establishing an interdisciplinary advisory board and inviting observers of other funding organisations. Tight <b>collaboration between academia and industry</b> aiming to fertilize the innovation process will occur on several levels. To adhere to ethical, legal and societal aspects as well as to technical issues like standardisation and infrastructure development ERASynBio will trace and integrate the ongoing work and research on these framework conditions and integrate them in the strategic research.<p/> | + | <p class="padding">The central idea of ERASynBio is <b>to promote the robust development of Synthetic Biology</b> by structuring and coordinating national efforts and investment. ERASynBio will develop a strategic research agenda / white paper, which will support the emergence of national Synthetic Biology programmes and which will lay the ground for transnational funding activities via joint calls in the project. ERASynBio will stimulate and tackle the interdisciplinary nature and immaturity by offering training and educational possibilities, establishing an interdisciplinary advisory board and inviting observers of other funding organisations. Tight <b>collaboration between academia and industry</b> aiming to fertilize the innovation process will occur on several levels. To adhere to ethical, legal and societal aspects as well as to technical issues like standardisation and infrastructure development ERASynBio will trace and integrate the ongoing work and research on these framework conditions and integrate them in the strategic research.<p/> |
<br/> | <br/> | ||
Revision as of 23:35, 2 September 2013
- iGEM 2013 Europe Platinum Partners
- In vitro diagnosis for more than 45 years and offers solutions of diagnosis: reagents to conduct biological tests to be able to identify different types of bacteria, viruses and to measure markers or specific hormones; instruments for automated testing and software to interpret the results of biological tests,
- Clinical application for the diagnosis of infectious diseases such as hepatitis, HIV, tuberculosis ans respiratory infections but also cardiovascular diseases and cancer based on biological samples analysis like blood, saliva, urine…,
- Industrial application for the analysis of industrial samples such as food, pharmaceutical and cosmetic products or environmental samples such as water, air surface to determine microbiological quality.
- iGEM 2013 Europe Gold Partners
- iGEM 2013 Europe Governmental Partners
- iGEM 2013 Europe Academic Partners
Biomérieux is established in each continent and in more than 160 countries and has more than 1000 collaborators.
Biomérieux is a world actor in the field of:
The central idea of ERASynBio is to promote the robust development of Synthetic Biology by structuring and coordinating national efforts and investment. ERASynBio will develop a strategic research agenda / white paper, which will support the emergence of national Synthetic Biology programmes and which will lay the ground for transnational funding activities via joint calls in the project. ERASynBio will stimulate and tackle the interdisciplinary nature and immaturity by offering training and educational possibilities, establishing an interdisciplinary advisory board and inviting observers of other funding organisations. Tight collaboration between academia and industry aiming to fertilize the innovation process will occur on several levels. To adhere to ethical, legal and societal aspects as well as to technical issues like standardisation and infrastructure development ERASynBio will trace and integrate the ongoing work and research on these framework conditions and integrate them in the strategic research.
